Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Darin Lippoldt currently holds 47,792 shares of NEUROCRINE BIOSCIENCES INC (NBIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Darin Lippoldt has been a net seller of NBIX stock. They have purchased $0 and sold $32.8M worth of shares.
Darin Lippoldt's most recent insider trade was on Jan 31, 2026, when they sold 2,373 shares at $0.00 per share.
Darin Lippoldt serves as Executive at NEUROCRINE BIOSCIENCES INC (NBIX). They have executed 139 insider transactions totaling $32.8M over their tenure at the company.
Darin Lippoldt holds the position of Executive at NEUROCRINE BIOSCIENCES INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Darin Lippoldt has shown a selling trading pattern, with $0 in total purchases and $32.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Darin Lippoldt was on Dec 6, 2023, when they sold $2.5M worth of NBIX shares. This transaction involved 20,830 shares at $119.86 per share.
Darin Lippoldt currently owns 47,792 shares of NEUROCRINE BIOSCIENCES INC (NBIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Darin Lippoldt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Darin Lippoldt has 139 Form 4 filings on record as an insider at NEUROCRINE BIOSCIENCES INC.
Set alerts for Darin Lippoldt and 40,000+ other insiders.